Researchers at UC Davis Health have engineered a novel antibody, FuG1, that can directly interfere with the cell-to-cell transmission ability of SARS-CoV-2, the virus that causes COVID-19.
Click here for original story, Engineered antibody helps block SARS-CoV-2 transmission
Source: Phys.org